Kurdish Oil Gambit Hits Troubled Waters

Related Link: 

Iraqi Kurdistan's recent efforts to sell its oil abroad, which Iraq has declared illegal, show the steep barriers Kurds face in becoming a legitimate player in international energy markets.

Apple Orders Massive Number of Bigger iPhones

Related Link: 

Apple is preparing for its largest initial production run of iPhones this year, betting that 4.7- and 5.5-inch screens will lure consumers now attracted to similar phones from Samsung and others.

Meat Supplier in China 'Appalled'

Related Link: 

The U.S. owner of a meat supplier in Shanghai apologized and promised a swift response after McDonald's and Yum suspended purchases in China amid allegations it sold expired chicken and beef to restaurants.

Xiaomi Reveals New Phone

Related Link: 

China's Xiaomi unveiled the fourth generation of its smartphone on Tuesday as part of its effort to build its presence in the world's largest smartphone market.

Swatch Pressured by Strong Swiss Franc

Related Link: 

Swatch said first-half net profit fell 12% as a persistently strong Swiss franc weighed on sales in countries such as the U.S. and China.

Dialog, AMS End Merger Talks

Related Link: 

The U.K.'s Dialog Semiconductor and Austrian sensor manufacturer AMS have terminated merger talks started in June as they failed to agree terms.

WH Group to Relaunch IPO

Related Link: 

WH Group, the pork producer that pulled its more than $5 billion initial public offering in April, plans to relaunch the deal Wednesday and is seeking to raise $2.05 billion.

ARM Boosted by Rise in Chip Shipments

Related Link: 

Computer-chip designer ARM Holdings reported a rise in second-quarter profit boosted by higher chip shipments and licensing revenue.

QinetiQ Cautious on Defense Equipment Sales

Related Link: 

British defense company QinetiQ said its outlook for defense equipment sales remains uncertain as the company embarks on a program to reduce dependence on those activities.

Actelion Lifts Guidance as Profit Rises

Related Link: 

Actelion's sales of a new drug helped push core earnings up by more than a quarter in the first half, a performance that prompted Europe's biggest biotech to raise its guidance for the year.

Syndicate content